MYLK and cancer: Many of these HBO1-dependent genes could exert oncogenic/cancer-promoting functions or being upregulated in NSCLC, including C‐C chemokine receptor type 2 (CCR2) 30, 31, myosin light chain kinase (MYLK) 32, VEGFR233, 34, ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) 35.